Trial Profile
A Randomized Controlled Study of Modified Cobratoxin (RPI-78M) in Adrenomyeloneuropathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs RPI 78M (Primary)
- Indications Adrenomyeloneuropathy
- Focus Adverse reactions; Therapeutic Use
- 20 Jul 2015 New trial record